Companies
West Pharmaceutical Services
S&P 500Health Care· USA

WST

Status-Quo-Player

West Pharmaceutical Services

$259.96

+1.36%

Open $256.19·Prev $256.48

as of 13 Apr

STATUS-QUO-PLAYER

Power Core

Power Core in one sentence: West's moat is the regulatory co-dependency between its engineered elastomeric components and the drug products they contain, making supplier substitution a regulatory event rather than a procurement decision.

Published1 Apr 2026
UniverseS&P 500
SectorHealth Care

Direction of Movement

Navigating Post-Pandemic Normalization Toward Structural Growth

ROC 200

+13.6%

This page is for informational purposes only and does not constitute investment advice. L17X Research is an independent research service.
WST — West Pharmaceutical Services — Power Mapping Analysis — L17X — L17X